Literature DB >> 21550623

Occupancy of chromatin organizers in the Epstein-Barr virus genome.

Meghan M Holdorf1, Samantha B Cooper, Keith R Yamamoto, J J L Miranda.   

Abstract

The human CCCTC-binding factor, CTCF, regulates transcription of the double-stranded DNA genomes of herpesviruses. The architectural complex cohesin and RNA Polymerase II also contribute to this organization. We profiled the occupancy of CTCF, cohesin, and RNA Polymerase II on the episomal genome of the Epstein-Barr virus in a cell culture model of latent infection. CTCF colocalizes with cohesin but not RNA Polymerase II. CTCF and cohesin bind specific sequences throughout the genome that are found not just proximal to the regulatory elements of latent genes, but also near lytic genes. In addition to tracking with known transcripts, RNA Polymerase II appears at two unannotated positions, one of which lies within the latent origin of replication. The widespread occupancy profile of each protein reveals binding near or at a myriad of regulatory elements and suggests context-dependent functions.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550623      PMCID: PMC3808970          DOI: 10.1016/j.virol.2011.04.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  50 in total

1.  B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids.

Authors:  B A Contreras-Brodin; M Anvret; S Imreh; E Altiok; G Klein; M G Masucci
Journal:  J Gen Virol       Date:  1991-12       Impact factor: 3.891

2.  The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells.

Authors:  L Sternås; T Middleton; B Sugden
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Two related Epstein-Barr virus membrane proteins are encoded by separate genes.

Authors:  J Sample; D Liebowitz; E Kieff
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells.

Authors:  M Biggin; M Bodescot; M Perricaudet; P Farrell
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

5.  trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

Authors:  D Reisman; B Sugden
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

6.  A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes.

Authors:  L Petti; J Sample; F Wang; E Kieff
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

7.  Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.

Authors:  M Woisetschlaeger; C N Yandava; L A Furmanski; J L Strominger; S H Speck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

8.  CTCF terminal segments are unstructured.

Authors:  Selena R Martinez; Jj L Miranda
Journal:  Protein Sci       Date:  2010-05       Impact factor: 6.725

9.  Transcriptional activity across the Epstein-Barr virus genome in Raji cells during latency and after induction of an abortive lytic cycle.

Authors:  E A Kirchner; G W Bornkamm; A Polack
Journal:  J Gen Virol       Date:  1991-10       Impact factor: 3.891

10.  Prediction and demonstration of a novel Epstein-Barr virus nuclear antigen.

Authors:  M J Allday; D H Crawford; B E Griffin
Journal:  Nucleic Acids Res       Date:  1988-05-25       Impact factor: 16.971

View more
  22 in total

1.  Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency.

Authors:  David J Hughes; Elessa M Marendy; Carol A Dickerson; Kristen D Yetming; Clare E Sample; Jeffery T Sample
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.

Authors:  Yen-Ju Chen; Yu-Lian Chen; Yao Chang; Chung-Chun Wu; Ying-Chieh Ko; Sai Wah Tsao; Jen-Yang Chen; Su-Fang Lin
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

Review 3.  The 2 micron plasmid: a selfish genetic element with an optimized survival strategy within Saccharomyces cerevisiae.

Authors:  Syed Meraj Azhar Rizvi; Hemant Kumar Prajapati; Santanu Kumar Ghosh
Journal:  Curr Genet       Date:  2017-06-08       Impact factor: 3.886

4.  Epigenetic deregulation of the LMP1/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding site.

Authors:  Horng-Shen Chen; Kayla A Martin; Fang Lu; Lena N Lupey; Joshua M Mueller; Paul M Lieberman; Italo Tempera
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

5.  Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters.

Authors:  Dinesh Verma; Trenton Mel Church; Sankar Swaminathan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-20       Impact factor: 11.205

Review 6.  Epigenetic regulation of EBV persistence and oncogenesis.

Authors:  Italo Tempera; Paul M Lieberman
Journal:  Semin Cancer Biol       Date:  2014-01-24       Impact factor: 15.707

Review 7.  Keeping it quiet: chromatin control of gammaherpesvirus latency.

Authors:  Paul M Lieberman
Journal:  Nat Rev Microbiol       Date:  2013-11-06       Impact factor: 60.633

8.  The open chromatin landscape of Kaposi's sarcoma-associated herpesvirus.

Authors:  Isaac B Hilton; Jeremy M Simon; Jason D Lieb; Ian J Davis; Blossom Damania; Dirk P Dittmer
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

Review 9.  Current Progress in EBV-Associated B-Cell Lymphomas.

Authors:  Yonggang Pei; Alexandria E Lewis; Erle S Robertson
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 10.  Utilization of Host Cell Chromosome Conformation by Viral Pathogens: Knowing When to Hold and When to Fold.

Authors:  Kinjal Majumder; Abigail J Morales
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.